Myfortic 180 mg

MYFORTIC 180 MG is an enteric-coated tablet containing mycophenolic acid (mycophenolate sodium). It is commonly used for immunosuppression in transplant patients. This medication helps prevent organ rejection by suppressing the immune system.

MYFORTIC 180 MG is primarily used to prevent organ rejection in patients who have undergone kidney, heart, or liver transplants. It works by suppressing the immune system to reduce the risk of the body rejecting the transplanted organ. This medication is often prescribed in combination with other immunosuppressants to enhance effectiveness. What is MYFORTIC used for? It is used for immunosuppression in transplant patients to help maintain organ function post-surgery.

Common effects of MYFORTIC 180 MG may include gastrointestinal issues such as diarrhea, nausea, and vomiting. Some users may also experience fatigue, headache, or infections. These effects vary among individuals and are not experienced by everyone who takes the medication.

MYFORTIC 180 MG should be handled with care, especially by pregnant women or those planning to become pregnant, as it can cause harm to an unborn baby. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Regular monitoring may be required to assess the medication's impact on the body.

MYFORTIC 180 MG may interact with other medications, including antacids, cholestyramine, and certain antibiotics. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should be avoided while taking this medication, as it can increase the risk of side effects.